Extracorporeal Membrane Oxygenation (ECMO) is a life support system that provides temporary respiratory and cardiac support to patients with severe heart or lung failure. ECMO machines use a pump to circulate blood through an artificial lung (oxygenator) and return it to the patient, allowing the heart and lungs to rest and heal.
Latest Extracorporeal Membrane Oxygenation Machine Companies Update
July 2023: MGM Healthcare, a multi-specialty hospital, recently established a centralized pediatric and newborn ECMO center. The establishment of this centralized center serves as a representation of our steadfast commitment to providing state-of-the-art medical interventions, with a specific focus on ECMO, which stands as the ultimate form of life support for children facing grave illnesses. Through the establishment of this center, the organization reiterates its commitment to providing young patients with many opportunities for recuperation and a hopeful, flourishing future. Extracorporeal membrane oxygenation (ECMO) is a therapeutic intervention that involves the extracorporeal circulation of a child's blood using a mechanical device, which facilitates both oxygenation and pumping. This process enables the restoration of oxygen-rich blood to the child's body, therefore facilitating the recovery of cardiac and pulmonary functions.
January 2023: the National Health Commission (NHC) of China officially authorized the introduction of the nation's first domestically produced extracorporeal membrane oxygenation (ECMO) equipment onto the market. The aforementioned equipment has been developed by Chinabridge Medical Technology Co. Ltd., which is a Sino-foreign joint company located in the southern Chinese city of Shenzhen. According to the official website of Chinabridge, the ECMO device is identified as the firm's primary product, with its development commencing at the establishment of the company in 2018. Extracorporeal membrane oxygenation (ECMO) has been included as a therapeutic modality in China's comprehensive strategy for managing and mitigating the impact of COVID-19.
Extracorporeal Membrane Oxygenation Machine Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)